Lexaria Bioscience Corp.(LEXX)
Pharmaceuticals
CNS / Psychiatry Pharma
Recent Insider Trades
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-07-30 | BUNKA CHRISTOPHER Director | Purchase | +27,500 | +5.27%549,455 | $0.92 | $25,241 | View SEC filing | |
| 2025-07-30 | McKechnie William Edward Director | Purchase | +5,000 | +27.49%23,191 | $0.91 | $4,532 | View SEC filing | |
| 2025-07-30 | DOCHERTY JOHN MARTIN President & CSO | Purchase | +5,376 | +5.62%101,118 | $0.93 | $4,989 | View SEC filing | |
| 2025-07-30 | Carle Vanessa Secretary | Purchase | +750 | +100.00%750 | $0.91 | $683 | View SEC filing | |
| 2025-07-30 | CHRISTOPHER RICHARD Chief Executive Officer | Purchase | +15,000 | +15.00%115,000 | $0.91 | $13,641 | View SEC filing | |
| 2024-12-03 | CHRISTOPHER RICHARD Chief Executive Officer | Purchase | +50,000 | +100.00%50,000 | $2.37 | $118,392 | View SEC filing | |
| 2024-08-13 | TURKEL CATHERINE C. Director | Purchase | +1,600 | +53.33%4,600 | $3.13 | $5,008 | View SEC filing | |
| 2024-08-01 | Carle Vanessa Secretary | Sale | -2,567 | -50.00%2,567 | $4.00 | $10,268 | View SEC filing | |
| 2023-02-27 | TURKEL CATHERINE C. Director | Purchase | +1,500 | +100.00%1,500 | $2.84 | $4,267 | View SEC filing | |
| 2022-10-18 | Downey Gregory Chief Financial Officer | Purchase | +121 | +3.30%3,787 | $2.09 | $253 | View SEC filing | |
| 2022-10-18 | BUNKA CHRISTOPHER Chief Executive Officer | Purchase | +38,500 | +7.96%521,955 | $2.04 | $78,397 | View SEC filing | |
| 2020-11-10 | BUNKA CHRISTOPHER CEO | Purchase | +195,500 | +3.11%6,477,344 | $0.20 | $39,769 | View SEC filing | |
| 2018-06-01 | Baxter Nicholas W Director | Purchase | +50,000 | +45.45%160,000 | N/A | N/A | View SEC filing | |
| 2018-05-31 | McKechnie William Edward Director | Sale | -50,000 | -14.89%285,738 | $1.90 | $95,001 | View SEC filing | |
| 2016-10-11 | BUNKA CHRISTOPHER CEO | Purchase | +20,000 | +0.28%7,235,579 | $0.13 | $2,515 | View SEC filing | |
| 2016-10-06 | BUNKA CHRISTOPHER CEO | Purchase | +2,500 | +0.03%7,215,579 | $0.14 | $363 | View SEC filing | |
| 2016-08-29 | BUNKA CHRISTOPHER CEO | Purchase | +5,100 | +0.07%7,213,079 | $0.13 | $653 | View SEC filing | |
| 2016-08-25 | BUNKA CHRISTOPHER CEO | Purchase | +27,637 | +0.38%7,207,979 | $0.13 | $3,545 | View SEC filing | |
| 2016-08-22 | BUNKA CHRISTOPHER CEO | Purchase | +19,800 | +0.28%7,180,342 | $0.13 | $2,494 | View SEC filing | |
| 2016-08-18 | BUNKA CHRISTOPHER CEO | Purchase | +13,340 | +0.19%7,160,542 | $0.13 | $1,774 | View SEC filing | |
| 2016-08-15 | BUNKA CHRISTOPHER CEO | Purchase | +10,000 | +0.14%7,147,202 | $0.15 | $1,500 | View SEC filing | |
| 2016-08-11 | BUNKA CHRISTOPHER CEO | Purchase | +450,000 | +9.05%5,421,844 | $0.06 | $27,000 | View SEC filing | |
| 2016-08-05 | BUNKA CHRISTOPHER CEO | Purchase | +5,000 | +0.07%7,137,202 | $0.13 | $645 | View SEC filing | |
| 2016-07-26 | BUNKA CHRISTOPHER CEO | Purchase | +24,083 | +0.34%7,132,202 | $0.12 | $2,910 | View SEC filing | |
| 2016-07-22 | BUNKA CHRISTOPHER CEO | Purchase | +7,500 | +0.11%7,108,119 | $0.12 | $932 | View SEC filing |
1-25 of 265
Page 1 of 11